FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 0 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 1 |
| Most recent action | December 19, 2025 |
Enforcement history
On 2025-12-19, Argus HQ recorded an FDA Form 483 inspection citation for F.H. Investments Inc dba Asteria Health, rated "high" severity in Argus HQ's classification: F.H. Investments Inc dba Asteria Health -- FDA 483: 8 observations (2025-12-19). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. F.H. Investments Inc dba Asteria Health has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- How many FDA actions does Argus HQ track for F.H. Investments Inc dba Asteria Health?
- 1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.
- What is the most recent FDA action on file for F.H. Investments Inc dba Asteria Health?
- December 19, 2025. Argus HQ ingests new FDA enforcement records daily.
- Is this FDA enforcement data for F.H. Investments Inc dba Asteria Health official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
- How many FDA actions has F.H. Investments Inc dba Asteria Health had?
- Argus HQ has recorded 1 FDA events for F.H. Investments Inc dba Asteria Health: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- F.H. Investments Inc dba Asteria Health vs Philips North America
- F.H. Investments Inc dba Asteria Health vs Medline Industries, LP
- F.H. Investments Inc dba Asteria Health vs Boston Scientific Corporation
- F.H. Investments Inc dba Asteria Health vs Baxter Healthcare Corporation
- F.H. Investments Inc dba Asteria Health vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Dec 19, 2025Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). Regulatory Record: F.H. Investments Inc dba Asteria Health. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/f-h-investments-inc-dba-asteria-health
"Regulatory Record: F.H. Investments Inc dba Asteria Health." Argus HQ Research, Digital Empire Holdings LLC, 2025, argushq.ai/company/f-h-investments-inc-dba-asteria-health.
Argus HQ Research. "Regulatory Record: F.H. Investments Inc dba Asteria Health." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/f-h-investments-inc-dba-asteria-health.
@misc{argushq_argushq_ai_company_f_h_investments_inc_dba_asteria_health_2025,
title = {Regulatory Record: F.H. Investments Inc dba Asteria Health},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/f-h-investments-inc-dba-asteria-health},
note = {Accessed: August 29, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗